ProPhase Labs (PRPH)

• Market cap: $14.8M
• 1 day: -2.56%
• 5 days: -7.54%
• 1 month: -2.56%
• 3 months: -22.18%
• 6 months: -49.11%
• Year to date: -62.35%
• 1 year: -92.88%
• 5 years: -78.35%
• 10 years: -76.50%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Employees: 96

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

23% more funds holding

Funds holding: 30 [Q4 2024] → 37 (+7) [Q1 2025]

6.59% more ownership

Funds ownership: 10.13% [Q4 2024] → 16.72% (+6.59%) [Q1 2025]

5% more capital invested

Capital invested by funds: $1.91M [Q4 2024] → $2.02M (+$103K) [Q1 2025]

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K